HIV-1 Vpr and anti-inflammatory activity

DNA and Cell Biology

Volumn 23, Issue 4, 2004, Pages 239-247

  Muthumani, Karuppiah ^a   Desai, Brijal M ^b   Hwang, Daniel S ^a   Choo, Andrew Y ^c   Laddy, Dominick J ^a   Thieu, Khanh P ^a   Rao, Rushil G ^a   Weiner, David B ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CHEMOKINE; CYTOKINE; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS PROTEIN; VPR PROTEIN;

ANTIINFLAMMATORY ACTIVITY; CELL KILLING; CONFERENCE PAPER; DOWN REGULATION; DRUG MECHANISM; DRUG POTENCY; HOST CELL; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATORY DISEASE; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; VIRUS INFECTION; VIRUS REPLICATION;

CHEMOKINES; DOWN-REGULATION; GENE PRODUCTS, VPR; HIV-1; HUMANS; INFLAMMATION; INTERLEUKIN-12; MODELS, BIOLOGICAL; NF-KAPPA B; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 2342524118     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454904773819824     Document Type: Conference Paper

References (56)

1. AYYAVOO, V., MAHALINGAM, S., RAFAELI, Y., KUDCHODKAR, S., CHANG, D., NAGASHUNMUGAM, T., WILLIAMS, W.V., and WEINER, D.B. (1997a). HIV-1 viral protein R (Vpr) regulates viral replication and cellular proliferation in T cells and monocytoid cells in vitro. J. Leukoc. Biol. 62, 93-99.
2. AYYAVOO, V., MAHBOUBI, A., MAHALINGAM, S., RAMALINGAM, R., KUDCHODKAR, S., WILLIAMS, W.V., GREEN, D.R., and WEINER, D.B. (1997b). HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B. Nat. Med. 3, 1117-1123.
3. AYYAVOO, V., MUTHUMANI, K., KUDCHODKAR, S., ZHANG, D., RAMANATHAN, P., DAYES, N.S., KIM, J.J., SIN, J.I., MONTANER, L.J., and WEINER, D.B. (2002). HIV-1 viral protein R compromises cellular immune function in vivo. Int. Immunol. 14, 13-22.
4. AUPHAN, N., DIDONATO, J.A., ROSETTE, C., HELMBER, A., and KARIN, M. (1995). Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science. 270, 286-290.
5. AZAD, A.A. (2000). Could Nef and Vpr proteins contribute to disease progression by promoting depletion of bystander cells and prolonged survival of HIV-infected cells? Biochem. Biophys. Res. Commun. 267, 677-685.
6. BAICHWAL, V.R., and BAEUERLE, P.A. (1997). Activate NF-kappa B or die? Curr. Biol. 7, R94-R96.
7. BALDWIN, A.S., JR. (1996). The NF-kappa B and I kappa B proteins: New discoveries and insights. Annu Rev. Immunol. 14, 649-683.
8. BARNES, D.M., and KARIN, M. (1997). Nuclear factor-kappaB: A pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med 336, 1066-1071.
9. COHEN, E.A., DEHNI, G., SODROSKI, J.G., and HASELTINE, W.A. (1990). Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J. Virol. 64, 3097-3099.
10. DIDONATO, J.A., HAYAKAWA, M., ROTHWARF, D.M., ZANDI, E., and KARIN, M. (1997). A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388, 548-554.
11. FIELDS, B.N., KNIPE, D.M., HOWLEY, P.M., CHANOCK, R.M., MONATH, T.P., MELNICK, J.L., ROIZMAN, B., and STRAUS, S.E. (2001). Virology (Lippincott Williams and Wilkins, New York), pp. 1884, 1893, 1886, 1888, 1890, 1892, 1901, 1917.
12. FINKEL, T.H., TUDOR-WILLIAMS, G., BANDA, N.K., COTTON, M.F., CURIEL, T., MONKS, C., BABA, T.W., and KUPFER, A. (1995). Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes. Nat. Med. 1, 129-134.
13. GEYER, M., FACKLER, O.T., and PETERLIN BM. (2001). Structure-function relationships in HIV-1 Nef. EMBO Rep. 2, 580-585.
14. GHOSH, S. MAY, M.J., and KOPP, E.B. (1998). NF-kappa B and Rel proteins: Evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
15. GOH, W.C., ROGEL, M.E., KINSEY, C.M., MICHAEL, S.F., FULTZ, P.N., NOWAK, M.A., HAHN, B.H., and EMERMAN, M. (1998). HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo. Nat. Med. 4, 65-71.
16. GREEN, D.R., and REED, J.C. (1998). Mitochondria and apoptosis. Science 281, 1309-1312.
17. HEINZINGER, N.K., BUKINSKY, M.I., HAGGERTY, S.A., RAGLAND, A.M., KEWALRAMANI, V., LEE, M.A., GENDELMAN, H.E., RATNER, L., STEVENSON, M., and EMERMAN, M. (1994). The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 91, 7311-7315.
18. th ed. (Garland Publishing, New York), p. 3.
19. JACOTOT, E., FERRI, K.F., EL HAMEL, C., BRENNER, C., DRUILLENNEC, S., HOEBEKE, J., RUSTIN, P., METIVIER, D., LENOIR, C., GEUSKENS, M., et al. (2001). Control of permeabilization by adenine nucleotide translocation interacting with HIV-1 viral protein R and Bcl-2. J. Exp. Med. 193, 509-519.
20. JACOTOT, E., RAVAGNAN, L., LOEFFLER, M., FERRI, K.F., VIEIRA, H.L.A., ZAMZAMI, N., COSTANTINI, P., DRUILLENNEC., HOEBEKE, J., BRIAND, J.P., et al. (2000). THE HIV-1 viral protein induces apoptosis via a direct effect on mitochondrial permeability transition pore. J. Exp. Med. 191, 33-46.
21. JOWETT, J.B., PLANELLES, V., POON, B., SHAH, N.P., CHEN, M.L., and CHEN, I.S. (1995). The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J. Virol. 69, 6304-6313.
22. KINO, T., GRAGEROV, A., KOPP, J.B., STAUBER, R.H., PAVLAKIS, G.N., and CHROUSOS, G.P. (1999). The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor. J. Exp. Med. 189, 51-62.
23. KROEMER, G., and REED, J.C. (2000). Mitochondria control of cell death. Nat. Med. 6, 513-519.
24. KROEMER, G., ZAMZAMI, N., and SUSIN, S.A. (1997). Mitochondria control apoptosis. Immunol. Today. 18, 44-51.
25. LEVY, D.N., FERNANDES, L.S., WILLIAMS, W.V., and WEINER, D.B. (1993). Induction of cell differentiation by human immunodeficiency virus 1 vpr. Cell 72, 541-550.
26. LEVY, D.N., REFAELI, Y., MACGREGOR, R.R., and WEINER, D.B. (1994). Serum Vpr regulates productive infection and latency of human immunodeficiencyvirus type 1. Proc. Natl. Acad. Sci. USA. 91, 10873-10877.
27. MAHALINGAM, S., AYYAVOO, V., PATEL, M., KIEBER-EMMONS, T., KAO, G.D., MUSCHEL, R.J., and WEINER, D.B. (1998). HIV-1 vpr interacts with a human 34k-Da mov34 homologue, a cellular factor linked to the G2/M phase transition of transition of the mammalian cell cycle. Proc. Natl. Acad. Sci. USA 95, 3419-3424.
28. MAHALINGAM, S., AYYAVOO, V., PATEL, M., KIEBER-EMMONS, T., and WEINER, D.B. (1997). Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 vpr. J. Virol. 71, 6339-6347.
29. MERCURIO, F., ZHU, H., MURRAY, B.W., SHEVCHENKO, A., BENNETT, B.L., LI, J., YOUNG, D.B., BARBOSA, M., MANN, M., MANNING, A., et al. (1997). IKK-1 and IKK-2: Cytokine-activated Ikappa B kinase essential for NF-kappa B activation. Science 278, 860-866.
30. MIYAMOTO, S., and VERMA, I.M. (1995). Rel/NF-kappa B/I kappa B story. Adv. Cancer Res. 66, 255-292.
31. MURO-CACHO, C.A., PANTALEO, G., and FAUCI, A.S. (1995). Analysis of apoptosis in lymph nodes of HIV-infected persons. Intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral load. J. Immunol. 154, 5555-5566.
32. MUTHUMANI, K., CHOO, A.Y., HWANG, D.S., CHATTERGOON, M.A., DAYES, N.N., ZHANG, D., LEE, M.D., DUVVURI, U., and WEINER, D.B. (2003). Mechanism of HIV-1 viral protein R-induced apoptosis. Biochem. Biophys. Res. Commun. 304, 583-592.
33. MUTHUMANI, K., HWANG, D.S., DESAI, B.M., ZHANG, D., DAYES, N., GREEN, D.R., and WEINER, D.B. (2002a). HIV-1 vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells. J. Biol. Chem. 277, 37820-37831.
34. MUTHUMANI, K., KUDCHODKAR, S., PAPASAVVAS, E., MONTANER, L.J., WEINER, D.B., and AYYAVOO, V. (2000). HIV-1 Vpr regulates expression of beta chemokines in human primary lymphocytes and macrophages. J. Leukoc. Biol. 68, 366-372.
35. MUTHUMANI, K., ZHANG, D., HWANG, D.S., KUDCHODKAR, S., DAYES, N.S., DESAI, B.M., MALIK, A.S., YANG, J.S., CHATTERGOON, M.A., MAGUIRE, H.C. JR., et al. (2002b). Adenovirus encoding HIV-1 vpr, activates caspase 9 and induces apoptotic cell death in both p53 positive and negative cell lines. Oncogene 21, 4613-4625.
36. PATEL, C.A., MUKHTAR, M., and POMERANTZ, R.J. (2002). Human immunodeficiency virus type 1 vpr induces apoptosis in human neuronal cells. J. Virol. 74, 9717-9726.
37. PAXTON, W.R., CONNOR, R.I., and LANDAU, N.R. (1993). Incorporation of vpr into human immunodeficiency virus type 1 virions: Requirement for the p6 region of gag and mutational analysis. J. Virol. 67, 7229-7237.
38. REFAELI, Y., LEVY, D.N., and WEINER, D.B. (1995). The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product. Proc. Natl. Acad. Sci. USA 92, 3621-3625.
39. SCHEINMAN, R.I., COGSWELL, P.C., LOFQUIST, A.K., and BALDWIN, A.S., JR. (1995). Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270, 283-286.
40. SHERMAN, M.P., DE NORONHA, C.M.C., HEUSCH, M.I., GREENE, S., and GREENE, W.C. (2001). Nucleocytoplasmic shuttling by human immunodeficiency virus type 1 vpr. J. Virol. 75, 1522-1532.
41. SHERMAN, M.P., DE NORONHA, C.M.C., PEARCE, D., and GREENE, W.C. (2000). Human immunodeficiency virus type 1 vpr contains two leucine-rich helices that mediate glucocorticoid receptor activation independently of its effects on G(2) cell cycle arrest. J. Virol. 74, 8159-8165.
42. SHERMAN, M.P., and GREENE, W.C. (2002). Slipping through the door: HIV entry into the nucleus. Microbes Infect 4, 67-73.
43. SHERMAN, M.P., SCHUBERT, U., WILLIAMS, S.A., DE NORONHA, C.M., KREISBERG, J.F., HENKLEIN, P., and GREENE, W.C. (2002). HIV-1 Vpr displays natural protein-transducing properties: Implications for viral pathogenesis. Virology 302, 95-105.
44. SHOSTAK, L.D., LUDLOW, J., FISK, J., PURSELL, S., RIMEL, B.J., NGUYEN, D., ROSENBLATT, J.D., and PLANELLES, V. (1999). Roles of p53 and caspases in the induction of cell cycle and apoptosis by HIV-1 vpr. Exp. Cell. Res. 251, 156-165.
45. SIEBENLIST, U., FRANZOSO, G., and BROWN, K. (1994). Structure, regulation, and function of NF-kappa B. Annu. Rev. Cell. Biol. 10, 405-455.
46. SINGH, S.P., LAI, D., CARTAS, M., SERIO, D., MURALI, R., KALYANARAMAN, S., and SRINIVASAN, A. (2000). Epitope-tagging approach to determine the stoichiometry of the structural and nonstructural proteins in the virus particles: Amount of Vpr in relation to Gag in HIV-1. J. Virol. 268, 364-371.
47. STEWART, S.A., POON, B., JOWETT, J.B.M., and CHEN, I.S.Y. (1997). Human immunodeficiency virus type 1 induces apoptosis following cell cycle arrest. J. Virol. 71, 5579-5592.
48. STEWART, S.A., POON, B., JOWETT, J.B.M., XIE, Y., and CHEN, I.S.Y. (1999). Lentiviral delivery of HIV-1 vpr protein induces apoptosis in transformed cells. Proc. Natl. Acad. Sci. USA 96, 12039-12043.
49. STEWART, S.A., POON, B., SONG, J.Y., and CHEN, I.S.Y. (2000). Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation. J. Virol. 74, 3105-3111.
50. SONENSHEIN, G.E. (1997). Rel/NF-kappa B transcription factors and the control of apoptosis. Semin. Cancer Biol. 8, 113-119.
51. SU, L., KANESHIMA, H., BONYHADI, M., SALIMI, S., KRAFT, D., RABIN, L., and MCCUNE, J.M. (1995). HIV-1-induced thymocyte depletion is associated with indirect cytopathogenecity and infection of progenitor cells in vivo. Immunity 2, 25-36.
52. th ed. (Quintessence Publishing Co, Inc. Chicago), pp. ix, 6-9, 130-140.
53. VEAZEY, R.S., DEMARIA, M., CHALIFOUX, L.V., SHVETZ, D.E., PAULEY, D.R., KNIGHT, H.L., ROSENZWEIG, M., JOHNSON, R.P., DESROSIERS, R.C., and LACKNER, A.A. (1998). Gastrointestinal tract as a major site of CD4= T cell depletion and viral replication in SIV infection. Science 280, 427-431.
54. YAO, X.J., SUBBRAMANIAN, R.A., ROUGEAU, N., BOISVERT, F., BERGERON, D., and COHEN, E.A. (1995). Mutagenic analysis of human immunodeficiency virus type 1 vpr: Role of predicted N-tenninal alpha helical structure in vpr nuclear localization and virion incorporation. J. Virol. 69, 7032-7044.
55. YUAN, X.Z., MATSUDA, Z., MATSUDA, M., ESSEX M., and LEE, T.H. (1990). Human immunodeficiency virus vpr encodes a virion associated protein. AIDS Res. Hum. Retroviruses 6, 1265-1271.
56. ZHAO, L.J., MUKHERJEE, S., and NARAYAN, O. (1994). Biochemical mechanism of HIV-1 vpr function. Specific interaction with a cellular protein. J. Biol. Chem. 269, 15577-15582.